United States  

Coronavirus Vaccine Shows Promising Early Results in China

NYTimes.com Friday, 22 May 2020
A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
0
shares
ShareTweetSavePostSend
 
Video Credit: Wochit - Published
News video: Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine 00:32

Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech company Moderna said the first phase of trials for a COVID-19 vaccine was tested on 45 human volunteers. Early data shows eight of the volunteers developed a type of...

You Might Like


💡 One News Page Knowledge: Other News Mentions

Coronavirus Coronavirus Subfamily of viruses in the family Coronaviridae

There may never be a 'silver bullet' for COVID-19: WHO [Video]

There may never be a 'silver bullet' for COVID-19: WHO

Despite vaccines in development, the head of the World Health Organization cautioned that the treatments had yet to prove effective and might only convey protection for a short time. This report produced by Zachary Goelman.

Credit: Reuters - Politics    Duration: 01:57Published
Advent Health | Morning Blend [Video]

Advent Health | Morning Blend

Dr. Michel Murr, bariatric surgeon from AdventHealth is here to talk to us about obesity, and its link to Coronavirus.

Credit: ABC Action News    Duration: 05:35Published
Covid-19 testing: The different types and why is it so important? [Video]

Covid-19 testing: The different types and why is it so important?

The Government has announced two new tests for coronavirus and flu, which canreturn results in just 90 minutes, are to be deployed in hospitals, care homesand laboratories from next week. The tests have been hailed as a crucialinstrument in the fight against the pandemic, especially as the UK heads intothe colder months. There are two types of test; the swab test and the finger-prick test, used to test if a person has Covid-19 or once had the virus. Thetwo current test available has some setbacks, mainly being the amount of timeit takes to process results, between 24-72 hours to get results. The mainthing with the news test, yet to be introduced, is the speed with which theyare able to detect not just Covid-19, but also other seasonal illnesses. Thiswill be crucial as Britain heads into winter, as will easily identify ifsufferers will need to self-isolate.

Credit: PA - Press Association STUDIO    Duration: 02:30Published
Latin America COVID-19 death toll rises past 200,000 [Video]

Latin America COVID-19 death toll rises past 200,000

The number of recorded Coronavirus deaths in Latin America doubles in just over a month.

Credit: Al Jazeera STUDIO    Duration: 01:59Published

Related videos from verified sources

Pitt Researches Says Coronavirus Vaccine Likely Won't Be Available Until Early 2021 [Video]

Pitt Researches Says Coronavirus Vaccine Likely Won't Be Available Until Early 2021

Dr. William Klimstra told Pennsylvania Auditor General Eugene DePasquale that he doesn't believe a coronavirus vaccine will be available until early next year.

Credit: KDKA CBS 2 Pittsburgh     Duration: 00:52Published
Coronavirus Vaccine From China Is Safe In Early Trial [Video]

Coronavirus Vaccine From China Is Safe In Early Trial

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse..

Credit: Wochit Business     Duration: 00:39Published
AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage..

Credit: Reuters Studio     Duration: 01:20Published

Related news from verified sources

S&P Stumbles as Moderna Sinks on Report Questioning Trial Results

The S&P 500 closed lower on Tuesday, as investors focused on a report questioning Moderna's recent coronavirus vaccine early-stage trial results, wiping out...
Newsmax Also reported by •NPRSeattle Times

Moderna: Early coronavirus vaccine results are encouraging

CAMBRIDGE, Mass. (AP) — An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses...
Seattle Times

Moderna: Early coronavirus vaccine results are encouraging

CAMBRIDGE, Mass. (AP) — An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses...
SeattlePI.com


Tweets about this